Table 1.
MSKCC Patient Baseline Demographics
| Variables | All | BRCA (-) | BRCA1/2 (+) | P-value* |
|---|---|---|---|---|
| Whole Cohort | 101 | 69 | 32 | |
| Age | ||||
| Median (mean) | 59.6 (58.5) | 62.1 (60.1) | 56.5 (55.1) | 0.01 |
| Range | 32.2 - 78.2 | 40.3 -78.2 | 32.2 - 74.0 | |
| Diagnosis | ||||
| Ovarian | 78 (77.2%) | 50 (72.5%) | 28 (87.5%) | 0.23 |
| Fallopian | 15 (14.9%) | 12 (17.4%) | 3 (9.4%) | |
| Peritoneum | 8 (7.9%) | 7 (10.1%) | 1 (3.1%) | |
| Pathologic Stage | ||||
| III | 86 (85.1%) | 59 (85.5%) | 27 (84.4%) | 1.00 |
| IV | 15 (15.6%) | 10 (14.5%) | 5 (15.6%) | |
| Grade | ||||
| G2/3 | 101 (100%) | 69 (100%) | 32 (100%) | -- |
| Surgical outcome | ||||
| 0 | 45 (44.6%) | 33 (47.8%) | 12 (37.5%) | 0.04 |
| 1-10mm | 40 (39.6%) | 22 (31.9%) | 18 (56.3%) | |
| >10mm | 16 (15.8%) | 14 (20.3%) | 2 (6.3%) | |
*
p-values for Diagnosis, Grade, OR Tumor Index by Pearson Chi-Square, Pathologic Stage, Surgical outcome by Fisher's Exact, age by ANOVA (all p-values are double-sided)